Early Phase Modelling – Estimating the Costs and Effectiveness of a Pharmaceutical before Clinical Trial

Duration: 55 minutes


If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch


This webinar offers an overview of the benefits early-phase, health-economic modelling can provide, at a stage when the outcome of the product development program is still largely unknown. Early-Phase Modelling balances between accuracy and manageability, and represents an easy to grasp, conceptual overview of your product and its potentials regarding reimbursement.

Key Learnings

  •  Health Economics 
  •  What is Modelling? 
  •  Early-Phase Modelling
  •  An Example of Early-Phase Modelling + Conclusions

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.

Åse Björstad

Senior Manager, Health Economics & Outcomes Research

Åse Björstad is a licensed pharmacist, and holds a PhD in Medicine with special emphasis on leukocyte biology from the University of Gothenburg, Sweden. Following her doctoral thesis, she held a position as a lecturer at the faculty of Pharmacy and Pharmaceutical Sciences at the University of Umeå. In 2010, she was recruited to Nordic Health Economics (now PharmaLex) and has since then gained 9 years of experience from hands-on work and project management within health economics and real-world evidence studies.